DK531089A - Bicycliske imidazolforbindelser til anvendelse ved behandling af hyperaldosteronisme - Google Patents
Bicycliske imidazolforbindelser til anvendelse ved behandling af hyperaldosteronismeInfo
- Publication number
- DK531089A DK531089A DK531089A DK531089A DK531089A DK 531089 A DK531089 A DK 531089A DK 531089 A DK531089 A DK 531089A DK 531089 A DK531089 A DK 531089A DK 531089 A DK531089 A DK 531089A
- Authority
- DK
- Denmark
- Prior art keywords
- hyperaldosteronism
- treatment
- imidazole compounds
- compounds
- bicyclic imidazole
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH399488 | 1988-10-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
DK531089D0 DK531089D0 (da) | 1989-10-25 |
DK531089A true DK531089A (da) | 1990-04-27 |
Family
ID=4267831
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK531089A DK531089A (da) | 1988-10-26 | 1989-10-25 | Bicycliske imidazolforbindelser til anvendelse ved behandling af hyperaldosteronisme |
Country Status (12)
Country | Link |
---|---|
US (1) | US5057521A (da) |
EP (1) | EP0366609B1 (da) |
JP (1) | JPH02169518A (da) |
KR (1) | KR900005976A (da) |
AT (1) | ATE104852T1 (da) |
AU (1) | AU631814B2 (da) |
CA (1) | CA2001301A1 (da) |
DE (1) | DE58907570D1 (da) |
DK (1) | DK531089A (da) |
IE (1) | IE63481B1 (da) |
IL (1) | IL92078A (da) |
ZA (1) | ZA898074B (da) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH683151A5 (de) * | 1991-04-24 | 1994-01-31 | Ciba Geigy Ag | Antikonzeption bei weiblichen Primaten ohne Beeinflussung des menstruellen Zyklus. |
US6333335B1 (en) | 1999-07-23 | 2001-12-25 | Merck & Co., Inc. | Phenyl-protein transferase inhibitors |
US20030083342A1 (en) * | 2002-08-27 | 2003-05-01 | Steele Ronald Edward | Combination of organic compounds |
ES2260303T3 (es) * | 2000-11-17 | 2006-11-01 | Takeda Pharmaceutical Company Limited | Derivados de imidazol, metodo para su produccion, y su uso. |
TW200611898A (en) * | 2004-05-28 | 2006-04-16 | Speedel Experimenta Ag | Organic compounds |
TW200616623A (en) * | 2004-05-28 | 2006-06-01 | Speedel Experimenta Ag | Organic compounds |
BRPI0510412A (pt) * | 2004-05-28 | 2007-10-23 | Speedel Experimenta Ag | compostos orgánicos |
TW200716105A (en) * | 2005-05-31 | 2007-05-01 | Speedel Experimenta Ag | Imidazole compounds |
GT200600381A (es) * | 2005-08-25 | 2007-03-28 | Compuestos organicos | |
TW200804378A (en) * | 2005-12-09 | 2008-01-16 | Speedel Experimenta Ag | Organic compounds |
EP1842543A1 (en) | 2006-04-05 | 2007-10-10 | Speedel Pharma AG | Pharmaceutical composition coprising an aldosterone synthase inhibitor and a mineralcorticoid receptor antagonist |
DE102008022221A1 (de) * | 2008-05-06 | 2009-11-12 | Universität des Saarlandes | Inhibitoren der humanen Aldosteronsynthase CYP11B2 |
US8541404B2 (en) * | 2009-11-09 | 2013-09-24 | Elexopharm Gmbh | Inhibitors of the human aldosterone synthase CYP11B2 |
TWI518073B (zh) * | 2011-06-14 | 2016-01-21 | 美國禮來大藥廠 | 醛固酮合成酶抑制劑 |
WO2018078049A1 (en) | 2016-10-27 | 2018-05-03 | Damian Pharma Ag | Aldosterone synthase inhibitor |
CA3097281A1 (en) | 2018-05-03 | 2019-11-07 | Damian Pharma Ag | R-fadrozole for use in the treatment of aldostonerism |
CN110507630A (zh) * | 2019-09-29 | 2019-11-29 | 陈汝霖 | 一种便携式腔道杀菌软胶囊 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4588732A (en) * | 1982-12-21 | 1986-05-13 | Ciba-Geigy Corporation | Certain imidazo(1,5-a)pyridine derivatives and their use as thromboxane synthetase inhibitors |
US4889861A (en) * | 1982-12-21 | 1989-12-26 | Ciba-Geigy Corp. | Substituted imidazo[1,5-a]pyridine derivatives and other substituted bicyclic derivatives and their use as aromatase inhibitors |
US4617307A (en) * | 1984-06-20 | 1986-10-14 | Ciba-Geigy Corporation | Substituted imidazo[1,5-A]pyridine derivatives as aromatase inhibitors |
US4728645A (en) * | 1982-12-21 | 1988-03-01 | Ciba-Geigy Corporation | Substituted imidazo[1,5-A]pyridine derivatives and other substituted bicyclic derivatives, useful as aromatase inhibitors |
-
1989
- 1989-09-26 US US07/412,369 patent/US5057521A/en not_active Expired - Fee Related
- 1989-10-17 AT AT8989810787T patent/ATE104852T1/de not_active IP Right Cessation
- 1989-10-17 EP EP89810787A patent/EP0366609B1/de not_active Expired - Lifetime
- 1989-10-17 DE DE58907570T patent/DE58907570D1/de not_active Expired - Fee Related
- 1989-10-22 IL IL9207889A patent/IL92078A/en not_active IP Right Cessation
- 1989-10-24 AU AU43722/89A patent/AU631814B2/en not_active Ceased
- 1989-10-24 CA CA002001301A patent/CA2001301A1/en not_active Abandoned
- 1989-10-25 DK DK531089A patent/DK531089A/da not_active Application Discontinuation
- 1989-10-25 IE IE344189A patent/IE63481B1/en not_active IP Right Cessation
- 1989-10-25 ZA ZA898074A patent/ZA898074B/xx unknown
- 1989-10-25 KR KR1019890015327A patent/KR900005976A/ko not_active Application Discontinuation
- 1989-10-26 JP JP1277326A patent/JPH02169518A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
AU631814B2 (en) | 1992-12-10 |
EP0366609B1 (de) | 1994-04-27 |
AU4372289A (en) | 1990-05-31 |
EP0366609A2 (de) | 1990-05-02 |
IE893441L (en) | 1990-04-26 |
KR900005976A (ko) | 1990-05-07 |
DK531089D0 (da) | 1989-10-25 |
ZA898074B (en) | 1990-08-29 |
DE58907570D1 (de) | 1994-06-01 |
CA2001301A1 (en) | 1990-04-26 |
ATE104852T1 (de) | 1994-05-15 |
IL92078A0 (en) | 1990-07-12 |
US5057521A (en) | 1991-10-15 |
IL92078A (en) | 1995-08-31 |
IE63481B1 (en) | 1995-05-03 |
JPH02169518A (ja) | 1990-06-29 |
EP0366609A3 (de) | 1992-01-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK531089D0 (da) | Bicycliske imidazolforbindelser til anvendelse ved behandling af hyperaldosteronisme | |
NL930044I2 (nl) | ImidazoÄ1,2-aÜ pyridinederivaten, de bereiding hiervan en de therapeutische toepassing. | |
BG103417A (en) | Condensed pyrimidine bicyclic derivatives | |
IT1205849B (it) | Derivati di indolo,procedimenti per prepararli e composizioni farmaceutiche che li contengono per il trattamento di emicrania | |
DK0802913T3 (da) | Imidazo[4,5-c]quinolinaminer | |
BG101934A (en) | Imidazo(1,2-a)pyridine derivatives | |
AU7689791A (en) | Drug-free method for treatment of alopecia | |
ES8308327A1 (es) | Un procedimiento para la preparacion de nuevos derivados biciclicos de piridin-5-ona. | |
NO954878L (no) | Pyrrolderivater | |
DK1109814T3 (da) | 5-Heterocyclylpyrazolo[4,3-d]pyrimidin-7-oner til behandling af mandlig erektil dysfunktion | |
AU549240B2 (en) | Imidazo(pyrimido)(1,2-c)quinazoles and imidazol(1,2-c( pyrido)2,3-e)pyrimidines | |
ID29790A (id) | PENGGUNAAN IMIDAZO(1,5-a)-PIRIDO(3,2-e)-PIRAZINON SEBAGAI OBAT | |
DE69908608D1 (de) | Derivate von Imidazo[1,2-a]pyridin zur Behandlung von gastrointestinalen Krankheiten | |
IT1216772B (it) | Derivati di indolo ,procedimento per prepararli e composizioni farmaceutiche che li contengono per il trattamento di emicrania | |
IL116931A (en) | Use of N2-¬¬2-¬4-(2-substituted-benzimidazol-L-YL(and imidazo¬4,5-b¾¬pyridin-1-YL)methyl)phenyl¾-cyclohexyl¾-carbonyl¾glycinamide derivatives in the preparation of pharmaceutical compositions for treatment of restenosis certain such novel compounds and their preparation | |
PT87634A (pt) | Process for the preparation of pharmaceutical compositions containing n-imidazolyl derivatives of bicyclic compounds useful for the treatment of nephrophies | |
DK1025101T3 (da) | Naphtho-imidazo[1,2-a]pyridinderivater, deres fremstilling og deres anvendelse ved behandlingen af sygdomme i centralnervesystemet | |
ES8308884A1 (es) | Procedimiento para la preparacion de nuevas imidazo(1,2-a)pirimidinas. | |
DE69400715D1 (de) | Verfahren zur Herstellung 4-halo-5(hydroxymethyl)-imidazol Derivate und neue 4-chloro-imidazol Verbindungen | |
HUP9801596A3 (en) | Use of azole compounds for preparing pharmaceutical compositions useful for the treatment of fungal infections, new azole derivatives and pharmaceutical compositions containing them | |
ES8307810A1 (es) | "procedimiento para la preparacion de nuevos 2-metilen-lh-2,3,5,6-tetrahidro-imidazoni,2-a imidazoles". | |
GB8812620D0 (en) | Pharmaceutical composition for treatment of migraine &c | |
PH24031A (en) | Pharmaceutical formulation for the treatment of androgenetic alopecia | |
SE8604669D0 (sv) | Medel for behandling av svampinfektioner i naglar |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AHB | Application shelved due to non-payment | ||
AHB | Application shelved due to non-payment |